AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 1072.50 Change Price %
High 1093.00 1 Day -1.20 -0.11
Low 1072.50 1 Week -46.90 -4.16
Close 1081.10 1 Month 138.20 14.66
Volume 1065897 1 Year 791.90 273.82
52 Week High 1152.40
52 Week Low 286.55
AUROPHARMA Important Levels
Resistance 2 1100.10
Resistance 1 1092.27
Pivot 1082.20
Support 1 1069.93
Support 2 1062.10
AUROPHARMA CURRENT MONTH FUTURE
Close 1079.60
Contracts Traded 14415
Open Intrest 1014500
Change In O.I -1342250
Lot Size 250
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 1100
Most Active put 1060
Highest O.I Buildup Call 1060
Highest O.I Buildup Put 1060
Expiry Date 27-Nov-2014
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
NIFTY 8494.20 0.22%
CROMPGREAV 191.70 -6.26%
UNITECH 19.35 2.11%
JPASSOCIAT 29.15 -1.69%
RASOYPR 2.75 -3.51%
GMRINFRA 19.85 -1.49%
ASHOKLEY 51.70 1.17%
DLF 148.25 -2.56%
HINDALCO 172.60 2.04%
SBIN 305.85 -0.13%
More..
NSE INDIA Top Gainers Stocks
KILITCH 42.40 19.94%
RMCL 37.85 19.78%
PROVOGE 7.05 19.49%
ATULAUTO 530.25 16.10%
ARCHIES 34.30 15.68%
ASHIMASYN 9.55 15.06%
SRGINFOTEC 0.40 14.29%
TAKE 53.85 12.77%
SOUISPAT 0.45 12.50%
SHREYANIND 34.00 10.93%
More..
NSE INDIA Top Losers Stocks
BLUECHIP 0.30 -14.29%
GLFL 2.55 -13.56%
CELEBRITY 13.00 -10.34%
TFL 6.20 -9.49%
SOMATEX 3.65 -8.75%
JAIHINDPRO 19.25 -8.11%
AGRODUTCH 2.30 -8.00%
JCTEL 0.60 -7.69%
AUSTRAL 0.60 -7.69%
PRAKASHSTL 131.45 -7.17%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 5
As on 27th Nov 2014 AUROPHARMA Share Price closed @ 1081.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 671.36 & Strong Buy for SHORT-TERM with Stoploss of 960.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for November
1st Target up-side 1037.83
2nd Target up-side 1086.46
3rd Target up-side 1135.09
1st Target down-side 899.07
2nd Target down-side 850.44
3rd Target down-side 801.81
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 68.32 Sideways
MFI (14) MFI is 54.52 Sideways
CCI (20) CCI is -13.16 Sideways
WILLIAM %R (14) William %R is -42.53 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 658.30
10 Day Avg Volume Traded 16.95 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Aurobindo Pharma tanks 5% despite strong fourth quarter nos   Moneycontrol.com   - 02nd Jun 14
TABLE-India's Aurobindo Pharma Jan-March net profit rises   Reuters   - 31st May 14
Aurobindo Pharma Q4 net spurts to Rs 501 cr   Hindu Business Line   - 30th May 14
Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr   Moneycontrol.com   - 30th May 14
Buy Aurobindo Pharma Ltd with a target of Rs 670: Mitesh Thacker   Economic Times   - 28th May 14
Reddy Becomes Billionaire as India's Aurobindo Shares Triple   Bloomberg   - 27th May 14
Aurobindo Pharma to announce FY14 results on May 30, 2014   Equity Bulls   - 27th May 14
Aurobindo Pharma rallies nearly 3%, hits fresh 52-week high on MSCI inclusion   Economic Times   - 15th May 14
Aurobindo Pharma hits new high   Business Standard   - 13th May 14
Aurobindo Pharma Limited   Moneycontrol.com   - 12th May 14
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.